Martina De Bortoli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martina De Bortoli has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Laurence Myriam Boon
Center for Vascular Anomalies, Division of Plastic Surgery, VASCERN VASCA European Reference Centre, Saint Luc University Hospital, Avenue Hippocrate 10, 1200 Brussels, Belgium
2 shared publications - Miikka Vikkula
Human Molecular Genetics, de Duve Institute, UCLouvain, Brussels, Belgium
2 shared publications - Raphaël Helaers
Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium
2 shared publications - An-Katrien De Roo
Department of Pathology Cliniques Universitaires Saint‐Luc Brussels Belgium
1 shared publication - Angela Queisser
Laboratory of Human Molecular Genetics, de Duve Institute, UCLouvain, Brussels, Belgium
1 shared publication - Anne Dompmartin
Dermatology Department, CHU Caen, Caen, France
1 shared publication
Latest Publications
- Open Access
- 29 February 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (9) , 2066-2077.e6
Somatic Loss-of-Function PIK3R1 and Activating Non-hotspot PIK3CA Mutations Associated with Capillary Malformation with Dilated Veins (CMDV)
- 29 February 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (9) , 2066-2077.e6
Open AccessSomatic Loss-of-Function PIK3R1 and Activating Non-hotspot PIK3CA Mutations Associated with Capillary Malformation with Dilated Veins (CMDV)
- Open Access
- 6 February 2024
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (6) , e63551
Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants
Capillary malformations (CMs) are the most common type of vascular anomalies, affecting around 0.3% of newborns. They are usually caused by somatic pathogenic variants in GNAQ or GNA11. PIK3CA and PIK3R1, part of the phosphoinositide 3‐kinase–protein kinase B–mammalian target of rapamycin pathway, are mutated in fainter CMs such as diffuse CM with overgrowth and megalencephaly CM. In this study, we present two young patients with a CM‐like phenotype associated with cerebral anomalies and severe epilepsy. Pathogenic variants in PIK3CA and PIK3R1, as well as GNAQ and GNA11, were absent in affected cutaneous tissue biopsies. Instead, we identified two somatic pathogenic variants in the AKT3 gene. Subsequent analysis of the DNA obtained from surgically resected brain tissue of one of the two patients confirmed the presence of the AKT3 variant. Focal cortical dysplasia was also detected in this patient. Genetic analysis thus facilitated workup to reach a precise diagnosis for these patients, associating the vascular anomaly with the neurological symptoms. This study underscores the importance of searching for additional signs and symptoms to guide the diagnostic workup, especially in cases with atypical vascular malformations. In addition, it strongly emphasizes the significance of genotype–phenotype correlation studies in guiding clinicians' informed decision‐making regarding patient care.
- 6 February 2024
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (6) , e63551
Open AccessEpilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants
Capillary malformations (CMs) are the most common type of vascular anomalies, affecting around 0.3% of newborns. They are usually caused by somatic pathogenic variants in GNAQ or GNA11. PIK3CA and PIK3R1, part of the phosphoinositide 3‐kinase–protein kinase B–mammalian target of rapamycin pathway, are mutated in fainter CMs such as diffuse CM with overgrowth and megalencephaly CM. In this study, we present two young patients with a CM‐like phenotype associated with cerebral anomalies and severe epilepsy. Pathogenic variants in PIK3CA and PIK3R1, as well as GNAQ and GNA11, were absent in affected cutaneous tissue biopsies. Instead, we identified two somatic pathogenic variants in the AKT3 gene. Subsequent analysis of the DNA obtained from surgically resected brain tissue of one of the two patients confirmed the presence of the AKT3 variant. Focal cortical dysplasia was also detected in this patient. Genetic analysis thus facilitated workup to reach a precise diagnosis for these patients, associating the vascular anomaly with the neurological symptoms. This study underscores the importance of searching for additional signs and symptoms to guide the diagnostic workup, especially in cases with atypical vascular malformations. In addition, it strongly emphasizes the significance of genotype–phenotype correlation studies in guiding clinicians' informed decision‐making regarding patient care.